SPECT and PET in ischemic heart failure.

Area of Science:

• Cardiovascular Imaging
• Nuclear Cardiology
• Heart Failure Diagnostics

Background:

• Heart failure is a widespread clinical syndrome with substantial global morbidity and mortality.
• Ischemic heart disease is the primary cause of heart failure in industrialized nations.
• Accurate diagnosis and management necessitate detailed anatomical and functional information via imaging.

Purpose of the Study:

• To review the role of nuclear cardiology, specifically SPECT and PET, in evaluating ischemic heart failure.
• To address controversies surrounding SPECT and PET guided therapy.
• To present technological advancements enhancing nuclear cardiology's utility in heart failure investigation.

Main Methods:

• Myocardial single-photon emission computed tomography (SPECT) using thallium-201 or technetium-99m tracers.
• Positron emission tomography (PET) for myocardial perfusion, metabolism, and viability assessment.
• Analysis of reported variations in sensitivity and specificity among imaging modalities.

Main Results:

• SPECT provides valuable data on ventricular function, perfusion, viability, and synchronism.
• PET enables quantitative analysis and high-quality imaging of perfusion, metabolism, and viability.
• Different techniques assess distinct cardiac parameters, leading to varied diagnostic performance.

Conclusions:

• Nuclear cardiology modalities (SPECT and PET) are integral to assessing ischemic heart failure.
• Ongoing technological innovations are poised to further solidify their role in patient investigation.
• Further research is needed to resolve controversies regarding SPECT and PET guided therapy.